Skip to content

The Oncology Institute, Inc. TOI Total costs & expenses

Total costs & expenses at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$506.85M+4.4%
Exelixis logo
ExelixisEXEL
$359.47M-2.5%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$732.3M-23.2%
Opko Health logo
Opko HealthOPK
$175.21M-19.3%
Incyte logo
IncyteINCY
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$147.4M+41.2%
Operating income-$6.5M+34.3%
Net income-$2.5M+87.3%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$30.3M-23.8%
Total debt$104.9M+2.5%
Total equity-$16.3M-421%
Total assets$168.2M+2.6%

Cash flow

See full
Operating cash flow-$2.2M+55.6%
CapEx$1.0M+218%
Free cash flow-$3.3M+38.7%

Valuation

See full
Market cap$511.91M+133%
Enterprise value$586.58M+108%
P/S0.9×+0.4×

Profitability

See full
Operating margin-6%-2.1pp
Net margin-8%-2.7pp
FCF margin-5.1%

Returns & leverage

See full
Return on equity-277.6%-700pp
Debt / equity20.2×+17.3×
Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingCostsAndExpenses.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Oncology Institute, Inc.'s total costs & expenses?
The Oncology Institute, Inc. (TOI) reported total costs & expenses of $153.95M in Q1 2026.
How has The Oncology Institute, Inc.'s total costs & expenses changed year-over-year?
The Oncology Institute, Inc.'s total costs & expenses increased by 34.7% year-over-year, from $114.32M to $153.95M.
What is the long-term trend for The Oncology Institute, Inc.'s total costs & expenses?
Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s total costs & expenses has grown at a 21.3% compound annual growth rate (CAGR), from $248.86M to $538.81M.
What does total costs & expenses mean?
This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue and maintain business operations. It encompasses cost of goods sold, selling, general and administrative expenses, research and development, and depreciation or amortization charges. Monitoring this figure is essential for evaluating the company's overall cost structure and operational efficiency relative to its revenue generation.